{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:04:56Z","timestamp":1789376696027,"version":"build-2803163510"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Prion diseases are a group of fatal neurological disorders characterized by the accumulation of misfolded prion protein, primarily concentrated in the brain. The development of a family of assays known as Quaking-Induced Conversion (QuIC), particularly Real Time (RT)-QuIC, has revolutionized prion disease diagnosis by detecting and amplifying minute quantities of misfolded prion protein into measurable signals. Despite these advancements, certain prion subtypes, such as rare inherited forms or atypical sporadic variants, can produce structural configurations that resist amplification. To address these limitations, we developed a modified QuIC-based assay to increase sensitivity across a wider spectrum of prion diseases. Through retrospective analysis of cerebrospinal fluid (CSF) and brain tissue samples from patients diagnosed with both sporadic Creutzfeldt\u2013Jakob disease (sCJD) and inherited prion diseases (IPDs), many of them historically problematic for conventional QuIC testing, we benchmark this modified assay against its predecessors. The updated assay demonstrated more consistent detection of disease-associated prion protein, successfully identifying cases that had previously yielded negative, inconclusive or borderline results. Given the transmissible nature of prion diseases, early and accurate diagnostic detection carries considerable weight in guiding patient care and counseling, as well as in broader public health surveillance. Taken together, these results demonstrate the strong diagnostic potential of this enhanced assay and support further prospective and independent evaluation toward its incorporation into standard diagnostic workflows for patients with suspected prion disease.<\/jats:p>","DOI":"10.3389\/fnins.2026.1919876","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:35:26Z","timestamp":1789374926000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent advancements in QuIC-based diagnostic assays for sporadic and inherited prion diseases: focusing on the emerging role of ES-QuIC"],"prefix":"10.3389","volume":"20","author":[{"given":"Rebecca","family":"Fox","sequence":"first","affiliation":[{"name":"High Consequence Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, MB, Canada"]},{"name":"Department of Medical Microbiology and Infectious Diseases, Rady Faculty of Health Sciences, University of Manitoba","place":["Winnipeg, MB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Myskiw","sequence":"additional","affiliation":[{"name":"High Consequence Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, MB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben A.","family":"Bailey-Elkin","sequence":"additional","affiliation":[{"name":"High Consequence Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, MB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Booth","sequence":"additional","affiliation":[{"name":"High Consequence Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, MB, Canada"]},{"name":"Department of Medical Microbiology and Infectious Diseases, Rady Faculty of Health Sciences, University of Manitoba","place":["Winnipeg, MB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1007\/s00415-019-09537-0","article-title":"Diagnostic value of surrogate CSF biomarkers for creutzfeldt-jakob disease in the era of RT-QuIC.","volume":"266","author":"Abu-Rumeileh","year":"2019","journal-title":"J. Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1003056","DOI":"10.3389\/fneur.2022.1003056","article-title":"Genetic aspects of human prion diseases.","volume":"13","author":"Appleby","year":"2022","journal-title":"Front. Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat. Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/19336896.2017.1283464","article-title":"Infectious prions and proteinopathies.","volume":"11","author":"Barron","year":"2017","journal-title":"Prion"},{"key":"B5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.euroneuro.2013.03.007","article-title":"Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?","volume":"25","author":"Bayer","year":"2015","journal-title":"Eur. Neuropsychopharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamaneurol.2016.4614","article-title":"Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples.","volume":"74","author":"Bongianni","year":"2017","journal-title":"JAMA Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/bmj.322.7290.841","article-title":"Bovine spongiform encephalopathy and variant creutzfeldt-jakob disease.","volume":"322","author":"Brown","year":"2001","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40249-016-0143-8","article-title":"Epidemiological characteristics of human prion diseases.","volume":"5","author":"Chen","year":"2016","journal-title":"Infect. Dis. Poverty"},{"key":"B9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","article-title":"Prion diseases of humans and animals:Their causes and molecular basis.","volume":"24","author":"Collinge","year":"2001","journal-title":"Annu. Rev. Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-025-02212-8","article-title":"Advancing prion diagnostics: Full-length human E200K RT-QuIC substrate facilitates prion detection in tear fluid and improves sensitivity in cerebrospinal fluid.","volume":"14","author":"Correia","year":"2026","journal-title":"Acta. Neuropathol. Commun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.14745\/ccdr.v41i08a01","article-title":"Creutzfeldt-Jakob disease mortality in Canada, 1998 to 2013.","volume":"41","author":"Coulthart","year":"2015","journal-title":"Can. Commun. Dis. Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","article-title":"Stability and reproducibility underscore utility of RT-QuIC for diagnosis of creutzfeldt-jakob disease.","volume":"53","author":"Cramm","year":"2016","journal-title":"Mol. Neurobiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/ijms21030880","article-title":"High Diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD.","volume":"21","author":"Fiorini","year":"2020","journal-title":"Int. J. Mol. Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24833","article-title":"Diagnostic and prognostic value of human prion detection in cerebrospinal fluid.","volume":"81","author":"Foutz","year":"2017","journal-title":"Ann. Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10655","DOI":"10.1038\/s41598-017-10922-w","article-title":"High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions.","volume":"7","author":"Franceschini","year":"2017","journal-title":"Sci. Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","article-title":"Sporadic and familial CJD: Classification and characterisation.","volume":"66","author":"Gambetti","year":"2003","journal-title":"Br. Med. Bull"},{"key":"B17","doi-asserted-by":"publisher","first-page":"gkag287","DOI":"10.1093\/nar\/gkag287","article-title":"Divalent siRNA for prion disease.","volume":"54","author":"Gentile","year":"2026","journal-title":"Nucleic. Acids Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1126\/science.1439789","article-title":"Fatal familial insomnia and familial creutzfeldt-jakob disease: Disease phenotype determined by a DNA polymorphism.","volume":"258","author":"Goldfarb","year":"1992","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/acn3.378","article-title":"Extended and direct evaluation of RT-QuIC assays for creutzfeldt-jakob disease diagnosis.","volume":"4","author":"Groveman","year":"2016","journal-title":"Ann. Clin. Transl. Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1212\/WNL.0000000000005860","article-title":"Validation and utilization of amended diagnostic criteria in creutzfeldt-jakob disease surveillance.","volume":"91","author":"Hermann","year":"2018","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s00415-022-11549-2","article-title":"Application of real-time quaking-induced conversion in creutzfeldt-jakob disease surveillance.","volume":"270","author":"Hermann","year":"2023","journal-title":"J. Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00401-017-1683-0","article-title":"Prion-specific and surrogate CSF biomarkers in creutzfeldt-jakob disease: Diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A\u03b242 levels.","volume":"133","author":"Lattanzio","year":"2017","journal-title":"Acta. Neuropathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000092794","article-title":"Barriers to autopsy: Creutzfeldt-Jakob disease in New York state.","volume":"26","author":"Lillquist","year":"2006","journal-title":"Neuroepidemiology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3201\/eid1009.040066","article-title":"Barriers to creutzfeldt-jakob disease autopsies, California.","volume":"10","author":"Louie","year":"2004","journal-title":"Emerg. Infect. Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1042\/bse0560181","article-title":"Prion disease and the \u2018protein-only hypothesis\u2019.","volume":"56","author":"Ma","year":"2014","journal-title":"Essays. Biochem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00441-022-03676-z","article-title":"Prion strains viewed through the lens of cryo-EM.","volume":"392","author":"Manka","year":"2023","journal-title":"Cell. Tissue Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0029225","DOI":"10.1128\/spectrum.00292-25","article-title":"Human PrP E219K: A new and promising substrate for robust RT-QuIC amplification of human prions with potential for strain discrimination.","volume":"13","author":"Mar\u00edn-Moreno","year":"2025","journal-title":"Microbiol. Spectr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.23589","article-title":"Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic creutzfeldt-jakob disease.","volume":"72","author":"McGuire","year":"2012","journal-title":"Ann. Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1056\/NEJMoa1214747","article-title":"A novel prion disease associated with diarrhea and autonomic neuropathy.","volume":"369","author":"Mead","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1038\/s41598-021-84527-9","article-title":"Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases.","volume":"11","author":"Mok","year":"2021","journal-title":"Sci. Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/ana.78162","article-title":"Enhanced sensitivity of a modified quaking-induced conversion diagnostic test for the broad detection of sporadic and inherited prion diseases: A retrospective study.","volume":"99","author":"Myskiw","year":"2026","journal-title":"Ann. Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a009064","article-title":"Bovine spongiform encephalopathy (BSE): Causes and consequences of a common source epidemic.","volume":"145","author":"Nathanson","year":"1997","journal-title":"Am. J. Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1371\/journal.ppat.0020012","article-title":"Efficient transmission and characterization of creutzfeldt-jakob disease strains in bank voles.","volume":"2","author":"Nonno","year":"2006","journal-title":"PLoS Pathog"},{"key":"B34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1315200","article-title":"A test for creutzfeldt-jakob disease using nasal brushings.","volume":"371","author":"Orr\u00fa","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e2451","DOI":"10.1128\/mBio.02451-14","article-title":"Rapid and sensitive RT-QuIC detection of human creutzfeldt-jakob disease using cerebrospinal fluid.","volume":"6","author":"Orr\u00fa","year":"2015","journal-title":"mBio"},{"key":"B36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3988\/jcn.2016.12.1.101","article-title":"Real-Time quaking-induced conversion analysis for the diagnosis of sporadic creutzfeldt-jakob disease in Korea.","volume":"12","author":"Park","year":"2016","journal-title":"J. Clin. Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"874734","DOI":"10.3389\/fnagi.2022.874734","article-title":"The use of real-time quaking-induced conversion for the diagnosis of human prion diseases.","volume":"14","author":"Poleggi","year":"2022","journal-title":"Front. Aging. Neurosci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e131175","DOI":"10.1172\/jci.insight.131175","article-title":"Antisense oligonucleotides extend survival of prion-infected mice.","volume":"5","author":"Raymond","year":"2019","journal-title":"JCI Insight"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","article-title":"Diagnosis of prion diseases by RT-QuIC results in improved surveillance.","volume":"95","author":"Rhoads","year":"2020","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/jnnp-2017-316853","article-title":"Imaging and CSF analyses effectively distinguish CJD from its mimics.","volume":"89","author":"Rudge","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1056\/NEJMc2214647","article-title":"Detection of prion protein seeding activity in tear fluids.","volume":"388","author":"Schmitz","year":"2023","journal-title":"N. Engl. J Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/brain\/awab350","article-title":"Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.","volume":"145","author":"Schmitz","year":"2022","journal-title":"Brain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3389\/fgene.2019.00895","article-title":"Genetic testing in prion disease: Psychological consequences of the decisions to know or not to know.","volume":"10","author":"Schwartz","year":"2019","journal-title":"Front. Genet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3390\/ijms26052037","article-title":"Challenges and revisions in diagnostic criteria: Advancing early detection of prion diseases.","volume":"26","author":"Shimamura","year":"2025","journal-title":"Int. J. Mol. Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/cjn.2020.139","article-title":"Prospective study demonstrates utility of EP-QuIC in creutzfeldt-jakob disease diagnoses.","volume":"48","author":"Simon","year":"2021","journal-title":"Can. J. Neurol. Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/cjn.2025.10088","article-title":"Diagnosis of creutzfeldt-jakob disease in Canada: An update on cerebrospinal fluid testing from 2016 to 2024.","author":"Slota","year":"2025","journal-title":"Can. J. Neurol. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/jnnp.2008.149922","article-title":"Prion mutation D178N with highly variable disease onset and phenotype.","volume":"80","author":"Synofzik","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1006491","DOI":"10.1371\/journal.ppat.1006491","article-title":"Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity.","volume":"13","author":"Wang","year":"2017","journal-title":"PLoS Pathog"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1003990","DOI":"10.1371\/journal.ppat.1003990","article-title":"Evidence that bank vole PrP is a universal acceptor for prions.","volume":"10","author":"Watts","year":"2014","journal-title":"PLoS Pathog"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1001217","DOI":"10.1371\/journal.ppat.1001217","article-title":"Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays.","volume":"6","author":"Wilham","year":"2010","journal-title":"PLoS Pathog"},{"key":"B51","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/bmb\/66.1.255","article-title":"Acquired prion disease: Iatrogenic CJD, variant CJD, kuru.","volume":"66","author":"Will","year":"2003","journal-title":"Br. Med. Bull"},{"key":"B52","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3967\/bes2020.081","article-title":"Assessment of the sensitivity and specificity of the established real-time quaking-induced conversion (RT-QuIC) technique in Chinese CJD surveillance.","volume":"33","author":"Xiao","year":"2020","journal-title":"Biomed. Environ. Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41572-024-00497-y","article-title":"Creutzfeldt-Jakob disease and other prion diseases.","volume":"10","author":"Zerr","year":"2024","journal-title":"Nat. Rev. Dis. Primers"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1919876\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:35:28Z","timestamp":1789374928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1919876\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":53,"alternative-id":["10.3389\/fnins.2026.1919876"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1919876","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"1919876"}}